2023 Annual Meeting | C10 - Child Neurology: Neuro-oncology

Date Saturday 04/22/23

Time 12:15 PM - 02:15 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Sonia Partap, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Neuro-oncology

Learning Objectives Participants should be able to understand the current treatment strategies of pediatric CNS tumors, become familiar with the acute neurologic sequelae related to tumor and or cancer therapies, and anticipate late neurologic effects in survivors of these cancers.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
12:15 PM - 12:55 PM EST	Speaker	Pediatric CNS Tumor Review and Updates Sonia Partap, MD, FAAN
12:55 PM - 01:35 PM EST	Speaker	Long-term Follow Up of Childhood Brain Tumor Survivors Nicole Ullrich, MD, PhD, MMSci, FAAN
01:35 PM - 02:15 PM EST	Speaker	Molecular Therapies in Neurocutaneous Syndromes and Low-grade Glioma Cynthia Campen, MD

Faculty Disclosures
Sonia Partap, MD, FAAN	The institution of Dr. Partap has received research support from NIH.
Nicole Ullrich, MD, PhD, MMSci, FAAN	Dr. Ullrich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care.
Cynthia Campen, MD	Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Campen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms. The institution of Dr. Campen has received research support from Greathouse Family Foundation.